Biodesix, Inc.
BDSX
Key stats
- Open
- 10.17
- Day high
- 10.87
- Day low
- 9.70
- Previous close
- 10.12
- Volume
- 297.1K
- VWAP
- 10.22
- 52-week high
- 31.97
- 52-week low
- 5.26
- Market cap
- 112.22M
- Shares out
- 10.55M
- Employees
- 334
- Listed
- 2020
About Biodesix, Inc.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
SERVICES-MEDICAL LABORATORIES · LOUISVILLE, CO · biodesix.com
Quarterly results
Massive · Nov 5, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $24.04M | $26.86M | $25.55M | $28.75M |
| Gross profit | $19.38M | $22.04M | $21.35M | $23.88M |
| Operating income | −$6.11M | −$5.39M | −$6.20M | −$1.97M |
| Net income | −$8.03M | −$7.27M | −$7.79M | −$3.98M |
| Diluted EPS | -0.75 | -0.71 | -0.81 | -0.49 |
| Operating cash flow | −$7.20M | −$1.56M | −$10.17M | $778.0K |
| Assets | $93.94M | $95.33M | $94.64M | $87.48M |
| Liabilities | $85.27M | $86.18M | $85.50M | $89.94M |
| Equity | $8.68M | $9.14M | $9.13M | −$2.46M |
Technicals
Massive · Nov 12, 2026- 50-day average24.23
- 200-day average18.88
- RSI (14 days)23.8
Short interest
Massive · Oct 30, 2026- Oct 30, 2026210.0K shares · 2.5 days to cover
- Oct 15, 2026209.5K shares · 2.4 days to cover
- Sep 30, 2026201.8K shares · 1.8 days to cover
- Sep 15, 2026214.0K shares · 3.3 days to cover
Splits
Massive · Sep 15, 2025- Sep 15, 20251-for-20
News coverage
No stories about Biodesix, Inc. right now.